BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 20728965)

  • 21. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
    Al-Tel TH
    Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties.
    Ali AR; El-Bendary ER; Ghaly MA; Shehata IA
    Eur J Med Chem; 2014 Mar; 75():492-500. PubMed ID: 24576591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
    Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
    Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New synthesis of two tridentate bipyrazolic compounds and their cytotoxic activity tumor cell lines.
    El Kodadi M; Benamar M; Ibrahim B; Zyad A; Malek F; Touzani R; Ramdani A; Melhaoui A
    Nat Prod Res; 2007 Sep; 21(11):947-52. PubMed ID: 17691042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of S-dialkylarsino-3-mercapto-1,2-propanediols and evaluation of their anticancer activity.
    Gao M; Tan S; Chen Y; Zingaro RA
    Bioorg Med Chem; 2007 Apr; 15(7):2660-6. PubMed ID: 17287125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and cytotoxicity evaluation of 1-[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]-3-aryl-1H-pyrazole-5-carboxylic acid derivatives.
    Nagarapu L; Gaikwad HK; Sarikonda K; Mateti J; Bantu R; Raghu PS; Manda KM; Kalvendi SV
    Eur J Med Chem; 2010 Nov; 45(11):4720-5. PubMed ID: 20817327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
    El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
    Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and biological evaluation of alcyopterosin A and illudalane derivatives as anticancer agents.
    Finkielsztein LM; Bruno AM; Renou SG; Moltrasio Iglesias GY
    Bioorg Med Chem; 2006 Mar; 14(6):1863-70. PubMed ID: 16321541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
    J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents.
    Bashir R; Ovais S; Yaseen S; Hamid H; Alam MS; Samim M; Singh S; Javed K
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4301-5. PubMed ID: 21664130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
    Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
    Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of a new class of 2-anilino substituted nicotinyl arylsulfonylhydrazides as potential anticancer and antibacterial agents.
    Kamal A; Khan MN; Srinivasa Reddy K; Rohini K
    Bioorg Med Chem; 2007 Jan; 15(2):1004-13. PubMed ID: 17097292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, characterization, electrochemical studies and antitumor activity of some new chalcone analogues containing ferrocenyl pyrazole moiety.
    Ratković Z; Juranić ZD; Stanojković T; Manojlović D; Vukićević RD; Radulović N; Joksović MD
    Bioorg Chem; 2010 Feb; 38(1):26-32. PubMed ID: 19846191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
    Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
    J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
    Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
    Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
    Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas.
    Comes Franchini M; Bonini BF; Camaggi CM; Gentili D; Pession A; Rani M; Strocchi E
    Eur J Med Chem; 2010 May; 45(5):2024-33. PubMed ID: 20129719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
    Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.